Cite

HARVARD Citation

    Martell, K. et al. (2019). Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients. Radiotherapy and oncology. pp. 149-155. [Online]. 
  
Back to record